Literature DB >> 10346421

A short term cost-effectiveness model for oral antidiabetic medicines in Europe.

L D MacKeigan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10346421     DOI： 10.2165/00019053-199814060-00010

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  A short term cost-effectiveness model for oral antidiabetic medicines in Europe.

Authors:  S C Hood; L Annemans; M Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  1998-03       Impact factor: 4.981
  1 in total
  1 in total

1.  Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada.

Authors:  Douglas Coyle; Andrew J Palmer; Robert Tam
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.